The consequence of oncomorphic TP53 mutations in ovarian cancer

Keyphrases

• Ovarian Cancer 100%
• TP53 mutation 100%
• Patient Response 33%
• Tumor 33%
• Oncogene 33%
• Poor Prognosis 33%
• Chemotherapy 33%
• Tumor Suppressor 33%
• Gain-of-function mutation 33%
• Mutant p53 Protein 33%
• Tumor Progression 33%
• Tumor Protein p53 (TP53) 33%
• Molecular Pathways 33%
• Drug Resistance 33%
• Response to Chemotherapy 33%
• Gynecologic Malignancies 33%
• Biological Markers 33%
• Drug Intervention 33%
• Drug Response 33%
• Chemoresistance 33%
• Serous Ovarian Tumor 33%
• Pathological Pathways 33%
• Tumor Chemoresistance 33%

Medicine and Dentistry

• Ovarian Cancer 100%
• Drug Resistance 100%
• Diseases 33%
• Cancer 33%
• Neoplasm 33%
• Tumor Progression 33%
• Oncogene 33%
• Protein P53 33%
• Tumor Suppressor Protein 33%
• Tumor Suppressor Gene 33%
• Biological Marker 33%
• Ovarian Tumor 33%
• Drug Response 33%
• Gain of Function Mutation 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Ovary Cancer 100%
• Drug Resistance 100%
• Chemotherapy 66%
• Tumor Suppressor Protein 66%
• Diseases 33%
• Neoplasm 33%
• Tumor Growth 33%
• Protein P53 33%
• Biological Marker 33%
• Ovary Tumor 33%